Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 117   

Articles published

JNJ 107.86 +0.38 (0.35%)
price chart
La Lumiere, with Johnson & Johnson's backing, expects big things from mask ...
Johnson & Johnson just invested $20 million in Jay Tapper's latest company, which has developed a mask that uses LED light to fight acne or wrinkles, depending on which version you buy.
Johnson & Johnson Seeks Payback In A Multi-Billion Trial With Boston Scientific
NEW YORK (Reuters) - Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp, Johnson & Johnson finally has a chance for payback at a multibillion-dollar trial set to begin on Thursday. A federal court judge in New ...
Will Boston Scientific (BSX) Stock Be Hurt Today by Johnson & Johnson ...  TheStreet.com
J&J Seeks Billions in Trial Over Decade-Old Bidding War  Bloomberg
Related articles »  
How Will Johnson & Johnson's Ebola Investment Pay Off?
In early September, Johnson & Johnson stated that it was accelerating the development of a vaccine against the Zaire strain of the Ebola Virus that has been responsible for the current outbreak in Africa.
Related articles »  
Does Johnson & Johnson Still Fit With Warren Buffett's Investing Strategy?
Although Berkshire's portfolio is predominantly focused on financials, one healthcare stock that Buffett has been attracted to, and of which his company currently owns 327,100 shares equaling about $35.4 million dollars, is healthcare conglomerate ...
Related articles »  
Save the Children Named Johnson & Johnson's First "Enterprise Wide" Global ...
New York City, NY (Nov. 19, 2014) - Save the Children and Johnson & Johnson announced today a global partnership that has the potential to help millions of children over the next three years.
Johnson & Johnson Partners with Save the Children to Help Millions of ...  MarketWatch
Johnson & Johnson announces global partnership with Save the Children  News-Medical.net
Related articles »  
Johnson & Johnson Takes Care Of Both Consumers And Stockholders (JNJ)
Johnson & Johnson (NYSE:JNJ) might be a household name for consumers providing a wide range of products from Band-Aids to mouthwash, but their business extends far deeper than many know.
Dow Component Johnson & Johnson (JNJ) To Go Ex-dividend Tomorrow  TheStreet.com
Johnson & Johnson (NYSE:JNJ) Synergy With Geron  WallStreet.org
Related articles »  
Johnson & Johnson's Partnership With Geron Emphasizes Its Push In Oncology
Johnson & Johnson has entered a partnership with Geron to develop its blood cancer treatment candidate, Imetelstat. The news sent the shares of Geron up by 40%, which means that for Geron's investors this is a big deal.
Johnson & Johnson: Good Medicine
Consumer (21%) makes the personal care and over-the-counter products Johnson & Johnson is perhaps best known for. In addition to Johnson's baby shampoo and Band-Aid bandages, brands include Neutrogena (moisturizer), Listerine (mouthwash) and ...
Johnson & Johnson Innovation Launches Asia Pacific Innovation Center and ...
Speaking at the opening of AusBiotech conference at the Gold Coast, Australia, Dong Wu, Head of the Johnson & Johnson Innovation Asia Pacific Innovation Center, said, "There is an explosion of growth in the Asia Pacific region, and China in particular, ...
Johnson & Johnson Innovation Launches Asia Pacific Innovation Center  Manufacturing.net
Related articles »  
Johnson & Johnson May Settle 1000 More DePuy ASR Hip Claims for $250 M
On the heels of Johnson & Johnson's win this week in its Pinnacle Hip implant trial, the pharmaceutical giant may offer $250 million to settle lawsuits not included in its previous offer to settle thousands of DePuy ASR hip claims from last year ...
J&J May Pay $250 Million to Settle 1000 More Hip Claims  Bloomberg
Related articles »